Diagnosis: Atrial Fibrillation with Prolonged QT Interval
This ECG shows atrial fibrillation with a significantly prolonged QT interval (QTcB 524 ms) that requires immediate attention to prevent life-threatening torsades de pointes arrhythmia.
ECG Interpretation
The ECG demonstrates classic atrial fibrillation characteristics 1:
- Irregularly irregular RR intervals (ventricular rate 73-120 bpm, mean 95 bpm)
- Absent P waves with irregular atrial activity
- Variable ventricular response confirming AF diagnosis
The QRS duration of 104 ms is at the upper limit of normal, and the QRS axis of -14° is within normal range.
Critical Finding: QT Prolongation
The corrected QT interval is dangerously prolonged, particularly using Bazett's formula (QTcB 524 ms), which exceeds the high-risk threshold of 500 ms associated with increased torsades de pointes risk 2.
Important Caveat About QT Correction in AF:
Bazett's formula significantly overcorrects QT intervals in atrial fibrillation, especially at higher heart rates 3, 4. The Fridericia correction (QTcF 485 ms) is more accurate in AF and shows the QT is still prolonged but less severely 3, 4. For clinical decision-making in AF, prioritize QTcF (485 ms) over QTcB 3, 4.
Normal QTc values 2:
- Men: <450 ms
- Women: <460 ms
- Definitely abnormal: ≥480 ms
- High risk for torsades: ≥500 ms
Immediate Management Algorithm
Step 1: Identify and Remove QT-Prolonging Triggers (URGENT)
Immediately review and discontinue all QT-prolonging medications 2:
High-risk "anti-drugs" to stop:
- Antibiotics: Fluoroquinolones (ciprofloxacin), macrolides (erythromycin > azithromycin)
- Safe alternatives: Cephalosporins, penicillins (no QT effect) 2
- Antipsychotics/Antidepressants: Citalopram (high risk) > sertraline (lower risk) 2
- Antiemetics: Ondansetron, metoclopramide
- Antifungals: Azoles
- Analgesics: Methadone
- Other: Chloroquine, triptans
Check www.crediblemeds.org for comprehensive drug list 2.
Step 2: Correct Electrolyte Abnormalities (URGENT)
Obtain STAT electrolytes and correct immediately 2:
- Potassium: Target >4.5 mEq/L (higher normal range protective)
- Magnesium: Target >2.0 mg/dL; give IV magnesium even if normal
- Calcium: Correct hypocalcemia
- Avoid hypokalemia-inducing diuretics
Step 3: Assess for Congenital Long QT Syndrome
Consider underlying congenital LQTS, especially if 2:
- History of unexplained syncope (exercise, swimming, loud noise triggers)
- Family history of sudden death
- QTc remains >480 ms after removing triggers
- Abnormal T-wave morphology
If suspected, refer to cardiac electrophysiology/LQTS specialist and consider:
- Exercise stress testing (abnormal QT prolongation at 4 minutes post-exercise diagnostic) 2
- Genetic testing
- Family screening
Step 4: Manage the Atrial Fibrillation
For rate control in AF with prolonged QT, use non-dihydropyridine calcium channel blockers as first-line 5, 1:
- Diltiazem or verapamil (preferred for rate control)
- Avoid: Beta-blockers if congenital LQTS suspected (can be used in acquired LQTS)
- Avoid: Digoxin alone (inadequate rate control during activity) 1
Target ventricular rate: <110 bpm at rest, <120-130 bpm to prevent tachycardia-induced cardiomyopathy 1.
Step 5: Anticoagulation Assessment
Assess stroke risk and initiate anticoagulation per CHA₂DS₂-VASc score 6, 7:
- Score ≥2 (men) or ≥3 (women): Direct oral anticoagulant (DOAC) recommended (Class I)
- Warfarin alternative if DOAC contraindicated (target INR 2.0-3.0)
Step 6: Monitor for Torsades de Pointes
If QTcF remains >500 ms or patient symptomatic:
- Continuous telemetry monitoring
- Have defibrillator immediately available
- Prepare IV magnesium sulfate (2g IV over 15 minutes, can repeat)
If torsades de pointes occurs:
- Immediate defibrillation if pulseless
- IV magnesium 2g bolus
- Correct electrolytes aggressively
- Consider temporary pacing/isoproterenol if recurrent
- Discontinue ALL QT-prolonging agents
Follow-Up Strategy
- Repeat ECG after removing triggers and correcting electrolytes (within 24-48 hours)
- Serial QTc monitoring until normalized (<480 ms)
- Comprehensive medication review before any new prescriptions
- Patient education on avoiding QT-prolonging drugs lifelong
- Cardiology follow-up within 1-2 weeks for rhythm management strategy discussion
Key Pitfalls to Avoid
- Do not rely on automated QTc calculations - manually measure QT in lead II or V5 2, 8
- Do not use Bazett's formula alone in AF - it overcorrects; use Fridericia 3, 4
- Do not use beta-blockers for rate control if congenital LQTS suspected - can worsen certain LQTS subtypes 2
- Do not discharge with QTcF >500 ms without addressing reversible causes 2
- Do not assume normal QTc rules out LQTS - "concealed" LQTS exists; exercise testing needed 2